STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Art's-Way Manufacturing SEC Filings

ARTW Nasdaq

Welcome to our dedicated page for Art's-Way Manufacturing SEC filings (Ticker: ARTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Looking for the numbers behind those bright-red grinder-mixers? Investors typically open Art's-Way Manufacturing filings to uncover how farm equipment demand stacks up against orders for its custom research labs. Our platform brings that story forward without forcing you through dense PDFs.

Start with the Art's-Way Manufacturing annual report 10-K simplified—AI pinpoints revenue by segment, steel-cost sensitivity, and dealer inventory trends in minutes. Move to each Art's-Way Manufacturing quarterly earnings report 10-Q filing when you need fresh backlog data or margin updates. Material announcements? Every Art's-Way Manufacturing 8-K material events explained entry lands here seconds after hitting EDGAR.

If you watch ownership moves in this thinly traded stock, real-time alerts flag Art's-Way Manufacturing Form 4 insider transactions real-time. Quickly scan Art's-Way Manufacturing insider trading Form 4 transactions or dive deeper into Art's-Way Manufacturing executive stock transactions Form 4—all with concise AI commentary. Planning to vote your shares? The Art's-Way Manufacturing proxy statement executive compensation section breaks down pay packages, option grants, and related-party deals.

Every document on this page is paired with an AI summary that turns regulatory jargon into clear language, delivering Art's-Way Manufacturing SEC filings explained simply. Use side-by-side metrics to compare quarters, export charts for your models, or follow our Art's-Way Manufacturing earnings report filing analysis for context on commodity cycles. Whether you’re a portfolio manager gauging exposure to grain prices or a researcher understanding Art's-Way Manufacturing SEC documents with AI, the information you need arrives the moment it’s filed—already distilled, already actionable.

Rhea-AI Summary

Art’s-Way Manufacturing (ARTW) reported Q3 2025 results. Sales were $6,432,296 with gross margin of 27.5%, and net income from continuing operations was $254,110 ($0.05 per share). Year-to-date, sales were $17,909,941 and net income from continuing operations reached $1,680,423 ($0.33 per share). Results benefited from Employee Retention Credit refunds recorded in other income of $1,620,103 and $246,108 of interest, offset by $405,026 of consulting fees.

Segment trends diverged: Modular Buildings delivered Q3 revenue of $3,449,000 and 35.4% gross margin, while Agricultural Products posted $2,983,000 and 18.3% margin. Cash was $5,960; inventories were $11,237,942. The revolving line of credit balance was $2,672,437 (7.5% rate) with $1,327,563 remaining available. Term debt totaled $2,006,259, including a 7.00% Bank Midwest loan and two SBA EIDL loans at 3.75%. Subsequent to quarter-end, the company entered a $516,971 roof loan at 7.25%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Art's-Way Manufacturing Co., Inc. filed a Current Report stating that it issued a press release announcing its financial results for the three- and nine-month periods ended August 31, 2025. The filing notes that the full press release text appears as Exhibit 99.1 and is incorporated by reference into the report. No financial statements, pro forma information, or shell company transactions are included in the filing itself.

The Item identifies the press release as the source of the announced results but clarifies that the information in Item 2.02 and Exhibit 99.1 is not being "filed" for Section 18 liability purposes and will not be incorporated by reference into registration statements unless specifically stated. The report is signed by the company’s Chief Financial Officer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Marc H. McConnell, who serves as President, CEO, Chairman and a director of Arts-Way Manufacturing Co., reported a purchase of 1,000 shares of Common Stock on 08/31/2025 under the director compensation plan as fully vested restricted stock. The Form 4 shows 220,500 shares reported as beneficially owned directly following the transaction and several indirect holdings: 5,580 shares held via an IRA, 5,000 shares held for each of two children, and 2,149,819 shares held indirectly through McConnell Legacy Investments, LLC, of which he is Managing Member. The filing also details multiple restricted-stock tranches subject to staggered vesting dates in 2026 and 2027–2028.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

David A. White, a director of Arts-Way Manufacturing Co Inc (ARTW), received a grant of 1,000 fully-vested restricted shares on 08/31/2025 under the companys director compensation plan. The grant was recorded at a transaction price of $0 and increased his reported beneficial ownership to 45,000 shares. The Form 4 was signed by an attorney-in-fact for Mr. White on 08/31/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Matthew Westendorf, a director of Arts-Way Manufacturing Co Inc (ARTW), was granted 1,000 fully-vested restricted shares on 08/31/2025 at a reported price of $0 under the director compensation plan. Following the award, Westendorf's beneficial ownership increased to 26,000 shares. The Form 4 was filed as a single reporting person filing and was signed by an attorney-in-fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Randall C. Ramsey, a director of Arts-Way Manufacturing Co., received 1,000 fully vested restricted shares on 08/31/2025 under the company's director compensation plan. The transaction was reported on a Form 4 filed pursuant to Section 16. Following the grant, Mr. Ramsey beneficially owns 72,709 shares of the issuer's common stock, held in a direct capacity.

The reported shares were granted at a $0 purchase price and are described as fully vested restricted stock. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Ramsey and contains an explanation that the award represents director compensation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Thomas E. Buffamante, a director of Arts-Way Manufacturing Co., acquired 1,000 shares of common stock on 08/31/2025 as fully-vested restricted stock under the company's director compensation plan. The transaction shows a $0 price for the grant and increases his beneficial ownership to 58,000 shares, reported as direct ownership. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on the same date. The filing does not disclose derivative transactions, amendments, or additional cash consideration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Michael W. Woods, identified as an officer and director of Arts-Way Manufacturing Co., reported two open-market sales of common stock: 4,074 shares sold at $3.769 on 08/06/2025 and 5,525 shares sold at $4.0501 on 08/07/2025. After the first reported sale his beneficial ownership was reported as 32,524 shares, and following the second sale it was 26,999 shares.

The filing also explains the composition of those holdings: portions are fully vested shares and portions are restricted stock subject to staged forfeiture-lapse schedules, with multiple tranches vesting on dates described in the form. No derivative securities were reported on this form.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Arts-Way Manufacturing Co. Inc. (ARTW) filed a Form 144 disclosing an insider’s plan to sell 5,525 common shares through NASDAQ on 08/07/2025. At an aggregate market value of $22,376.80 (~$4.05/sh), the proposed sale equals 17.1 % of the 32,254 shares outstanding stated in the notice.

The stock was acquired via four stock-award grants: 1,022 shares on 01/31/2020 and three blocks of 1,501 shares each in January 2024. The filer—identified as Michael Woods in the recent-sales table—already sold 11,666 shares during the past three months, generating $40,488.23 in gross proceeds (7,592 shares on 07/29/2025 and 4,074 shares on 08/06/2025). Should the new sale proceed, insider dispositions over the period would total 17,191 shares, or 53.3 % of the shares outstanding.

The signing party affirms no undisclosed material adverse information. While the dollar amount is modest, the large percentage of shares involved may increase float and exert supply pressure, meriting close investor attention.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Art's-Way Manufacturing (ARTW)?

The current stock price of Art's-Way Manufacturing (ARTW) is $2.26 as of November 24, 2025.

What is the market cap of Art's-Way Manufacturing (ARTW)?

The market cap of Art's-Way Manufacturing (ARTW) is approximately 10.8M.
Art's-Way Manufacturing

Nasdaq:ARTW

ARTW Rankings

ARTW Stock Data

10.83M
2.41M
52.74%
3.21%
0.01%
Farm & Heavy Construction Machinery
Farm Machinery & Equipment
Link
United States
ARMSTRONG